Oncology Clinical Trials - Global Strategic Business Report 2026: Secure Share of a $6 Billion Revenue Surge by 2032 as AbbVie, AstraZeneca, ICON, Merck, and Roche Accelerate AI-Led Trials

Company Logo Dublin, Nov. 20, 2026 (GLOBE NEWSWIRE) -- "Oncology Clinical Trials - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The g…